Study to Create Potential Cell-Based Therapies to Treat Human Disease and Disability

This is a research study in which your cells will be used for somatic cell nuclear transfer (SCNT), and/or genetic reprogramming research which may result in the production of stem cell lines. This study does not provide treatment.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Conditions

Metabolic Diseases Genital Diseases Infertility Nutritional and Metabolic Diseases Urogenital Diseases

Age range

1 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Stanford University School of Medicine

Stanford, California, 94305, United States

About this study

It is thought that studies of genetic reprogramming and SCNT using human cells have the potential to give us new basic knowledge about human development. Current work will focus on developing this basic knowledge. In the future, human embryonic stem cell lines (hESC) derived from genetic reprogramming and SCNT may also have the potential to develop into cell types that are useful for cell-based therapies to treat human disease and disability.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

1. Donors with a degenerative disease phenotype or genetic disorders such as Type I Diabetes, heart disease, or infertility (azoospermia and premature ovarian failure)

Exclusion criteria

1. Unable to read or understand English. 2. Unable to provide skin biopsy sample due to skin condition in the underarm area.

Treatment and study plan

Improving the scientific process of human cell reprogramming

Procedure

Sponsors and collaborators

Lead sponsor

Stanford University

Other

Registry information

Official study title

Derivation of Primary Donor Cell Lines for Human Cell Reprogramming

Important dates

Study start: 2007
Primary completion: 2030
Study completion: 2030
First posted: Mar 4, 2008
Registry last updated: Aug 12, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed